Notes:
PLEASE NOTE: THIS CHAPTER IS STILL UNDER CONSTRUCTION
This chapter contains information from BCAP, Microguide and 3T's but a joint finalised version has yet to be agreed. Please use the information presented here in combination with the appropriate local guidelines.
Paediatric Drugs and the Traffic Light System
This guidance applies:
- only where a drug does not already have a TLS classification
- only for long-term use of a medicine where the patient would not otherwise visit the initiating clinician or unit at intervals of 60 days or less
Paediatric drugs are frequently used outside the makers Summary of Product Characteristics since many manufacturers fail to conduct the relevant trials needed to secure licensed use in paediatrics. Local guidance has made clear that the BNF for Children is the accepted reference.
|
Drug Indication
|
In BNF-C for indication and dose range
|
In BNF-C but outside indications or dose range Not in BNF-C
|
|
Licensed drug within SPC indications
|
Amber No Shared Care Protocol (SCP) needed
|
Red
|
|
Off label use of drug (as per BNF-C definition page 2)
|
Amber if SCP agreed
|
Red
|
|
Unlicensed drug
|
Amber if SCP agreed
|
Red
|
RCPCH and NPPG joint position statement -
https://www.rcpch.ac.uk/resources/using-standardised-strengths-unlicensed-liquid-medicines-children-joint-position |
